CORBILTA

This brand name is authorized in Austria, Estonia, France, Italy, Lithuania, Netherlands, Poland

Active ingredients

The drug CORBILTA contains a combination of these active pharmaceutical ingredients (APIs):

1 Carbidopa
UNII MNX7R8C5VO - CARBIDOPA

Carbidopa is a peripheral aromatic amino acid decarboxylase inhibitor. It prevents metabolism of levodopa to dopamine in the peripheral circulation, ensuring that a higher proportion of the dose reaches the brain, where dopamine exerts its therapeutic effects. A lower dose of levodopa can be used when it is coadministered with carbidopa, reducing the incidence and severity of peripheral side effects.

Read about Carbidopa
2 Entacapone
UNII 4975G9NM6T - ENTACAPONE

Entacapone belongs to a new therapeutic class, catechol-O-methyl transferase (COMT) inhibitors. It is a reversible, specific, and mainly peripherally acting COMT inhibitor designed for concomitant administration with levodopa preparations. Entacapone prolongs the clinical response to levodopa.

Read about Entacapone
3 Levodopa
UNII 46627O600J - LEVODOPA

According to the current understanding, the symptoms of Parkinson’s disease are related to depletion of dopamine in the corpus striatum. Dopamine does not cross the blood-brain barrier. Levodopa, the precursor of dopamine, crosses the blood brain barrier and relieves the symptoms of the disease.

Read about Levodopa

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CORBILTA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BA Dopa and dopa derivatives
Discover more medicines within N04BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1632237, 1632248, 1632259, 1632260, 1632271, 1699780, 1699791, 1699803, 1699814, 1699825, 1699836, 1699847, 1699858, 1699869, 1699870, 1699881, 1699892, 1699904, 1699915, 1699926, 1699937, 1699948, 1699959, 1699960, 1699971, 1699982, 1699993, 1700008, 1700019, 1700020, 1700031, 1700042, 1700053, 1700064, 1700075, 1700086, 1700097
Country: FR Base de données publique des médicaments Identifier(s): 67719818, 69355498
Country: IT Agenzia del Farmaco Identifier(s): 043152038, 043152091, 043152141, 043152204, 043152255, 043152368
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1072027, 1072028, 1072029, 1072030, 1072031, 1072032, 1072033, 1072034, 1072035, 1072036, 1072037, 1072038, 1072039, 1072040, 1072041, 1072042, 1072043, 1072044, 1072045, 1072046, 1072047, 1072048, 1072049, 1072050, 1072051, 1072052, 1072053, 1072054, 1072055, 1072056, 1072057, 1072058, 1072059, 1072060, 1072061, 1072062, 1072063, 1072064
Country: NL Z-Index G-Standaard, PRK Identifier(s): 119938, 119946, 119954, 86703, 89680, 89699
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100311493, 100311501, 100311518, 100311524, 100311530, 100311547, 100311553

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.